Abstract:Objective To evaluate the role of calcium/calmodulin-dependent protein kinase Ⅱ (CaMK Ⅱ) in cognitive dysfunction caused by chronic pain in rats.Methods The experiment was performed in 2 parts.In experiment Ⅰ,24 pathogen-free male Sprague-Dawley rats,weighing 180-220 g,were randomly divided into 4 groups (n =6 each) using a random number table:sham operation group (group S),m-AIP injected before sham operation group (group M-S),chronic sciatic nerve injury group (group N-C),and m-AIP injected before chronic constriction injury (CCI) group (group M-C).The sciatic nerve was only exposed but not ligated.Chronic pain was induced by CCI in N-C and M-C groups.The animals were anesthetized with intraperitoneal 1％ pentobarbital sodium.The sciatic nerve was exposed and 4 ligatures were placed on the sciatic nerve at 1 mm intervals.Normal saline 20 μ1 and m-AIP 20 μ/ were injected intrathecally at 15 min before sham operation in S and M-S groups,respectively,and at 15 min before CCI in N-C and M-C groups,respectively.The mechanical paw withdrawal threshold (MWT) and thermal paw withdrawal latency (TWL) were measured before CCI and on 4,7,10,14,17,21 and 28 days after CCI.Step-through latency (STL) was measured before CCI and on 7,14,21 and 28 days after CCI.In experiment Ⅱ,18 pathogen-free male Sprague-Dawley rats,weighing 180-220 g,were randomly divided into 3 groups (n =6 each) using a random number table:m-AIP injected after sham operation group (group C-N),control after CCI group (group C-N) and m-AIP injected after CCI group (group C-M).Group S-M received intrathecal injection of m-AIP 20 μl at 7 days after sham operation.Normal saline 20 μl and m-AIP 20 μ/ were injected intrathecally at 7 days after CCI in C-N and C-M groups,respectively.MWT,TWL and STL were measured before administration and at 2,4 and 8 h after administration.Results In experiment Ⅰ,compared with group S,MWT was significantly decreased at each time point after CCI,TWL was shortened at each time point after CCI and STL was shortened on 7,14 and 21 days after CCI in N-C group,and MWT was significandy decreased at each time point,TWL was shortened at each time point,and STL was shortened on 14 and 21 days after CCI in group M-C.Compared with group N-C,MWT was significantly increased on 4,7 and 10 days after CCI,TWL was prolonged on 4 and 7 days after CCI,and STL was prolonged on 7 days after CCI in group M-C.In experiment Ⅱ,compared with group S-M,MWT was significantly decreased,and TWL and STL were shortened at each time point after administration in C-N group,and TWL at 8 h after administration and STL at each time point after administration were shortened,MWT was decreased at 8 h after administration,and no significant change was found in MWT and TWL at 2 and 4 h after administration in group C-M Compared with group C-N,MWT was significantly increased,and TWL was prolonged at 2 and 4 h after administration,and no significant change was found in STL at each time point after administration in group C-M.Conclusion CaMK Ⅱ is involved in the development of cognitive dysfunction caused by chronic pain in rats.

Role of CaMK II in primary somatosensory area and hippocampi in reduction of remifentanil-induced hyperalgesia by lidocaine in rats

Dezocine Attenuates the Remifentanil-Induced Postoperative Hyperalgesia by Inhibition of Phosphorylation of CaMKⅡα.

Ketamine Reduces Remifentanil-Induced Postoperative Hyperalgesia Mediated by CaMKII-NMDAR in the Primary Somatosensory Cerebral Cortex Region in Mice.

Effect of intraperitoneal injection of Lidocaine on expression of NMDAR1 in spinal dorsal horn of a rat model of incisional pain

Effects of CaMK Ⅱ Inhibitor KN93 on Remifentanil-Induced Hyperalgesia

Antinflammatory pain effect of ifenprodil administrated subarachnoidly

Role of Spinal Protein Kinase C in Remifentanil-Induced Hyperalgesia in Rats with Incisional Pain: the Relationship with Phosphorylation of NR1

The Influence of Ketamine on KCC2 in Spinal Cord of Rat in Remifentanil-Induced Hyperalgesia

Effects of Different Dose of KN93 on Remifentanil-Induced Hyperalgesia

Blocking SphK/S1P/S1PR1 axis signaling pathway alleviates remifentanil-induced hyperalgesia in rats

Intrathecal Injection of KN93 Attenuates Paradoxical Remifentanil-Induced Postoperative Hyperalgesia by Inhibiting Spinal CaMKII Phosphorylation in Rats

Effect of Verapamil on Expression of K+·Cl-cotransporter 2 in Spinal Dorsal Horns During Remifentanil-Induced Hyperalgesia in a Rat Model of Incisional Pain

Effect of ketamine on remifentanil induced hyperalgesia in incision pain rats

Effects of Ketamine Pretreatment on Preventing Remifentanil-Induced Hyperalgesia

Ciprofol alleviates remifentanil-induced hyperalgesia by regulating α2GABAARs, NR2B, and P-CaMKIIα levels in the spinal cord and hippocampus

Role of Neuron-Restrictive Silencer Factor in Spinal Cord in Remifentanil-Induced Hyperalgesia in a Mouse Model of Incisional Pain

Role of Calcium/calmodulin-Dependent Protein Kinase Ⅱ in Cognitive Dysfunction Caused by Chronic Pain in Rats

Tyrosine Phosphorylation of the N-Methyl-D-Aspartate Receptor 2B Subunit in Spinal Cord Contributes to Remifentanil-Induced Postoperative Hyperalgesia: the Preventive Effect of Ketamine

[Changes of Mu-opioid receptor and neuron-restrictive silencer factor in periaquductal gray in mouse models of remifentanil-induced postoperative hyperalgesia]

The roles of glycine-transporter 1 inhibiter in remifentanil induced hyperalgesia in rats incision pain model

Prevention of Remifentanil Induced Postoperative Hyperalgesia by Dexmedetomidine Via Regulating the Trafficking and Function of Spinal NMDA Receptors As Well As PKC and CaMKII Level in Vivo and in Vitro